Breast Cancer
Conference Coverage
One-week radiotherapy course should be standard for early invasive breast cancer, experts say
Two 1-week adjuvant radiotherapy regimens for breast cancer are as effective as the standard 3-week regimen, the FAST-Forward trial suggests.
Conference Coverage
After 48 years, NCI aims to track breast cancer recurrences
News
U.S. mothers underestimate role breastfeeding plays in curbing breast cancer
Only 36% of U.S. mothers currently breastfeed as recommended.
Article
Updates in HER2-positive Metastatic Breast Cancer Clinical Trials from SABCS 2020
Dr. Sara Hurvitz shares updates in HER2-positive metastatic breast cancer clinical trials from the 2020 San Antonio Breast...
Conference Coverage
Study: Doctors underreport side effects of breast irradiation
A large study shows a mismatch between patient and physician reports of toxicity.
Conference Coverage
No edge for anastrozole over tamoxifen in DCIS
Breast cancer recurrence rates were similar at almost 12 years of follow-up.
Opinion
Reproductive Rounds: Fertility preservation options for cancer patients
These two diseases intersect in the burgeoning field of oncofertility, the collaboration of oncology with reproductive endocrinology to offer...
Conference Coverage
Long-term APBI cosmetic, toxicity data reported
Conference Coverage
Omitting postop radiotherapy doesn’t affect survival in older breast cancer patients
PRIME-2 study results show no drop in overall survival from omitting postop radiotherapy in older women with HR+, low-risk, early-stage breast...
News
Margetuximab approved for HER2-positive metastatic breast cancer
The monoclonal antibody margetuximab-cmkb demonstrated superiority over trastuzumab.